SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-035171
Filing Date
2022-03-17
Accepted
2022-03-17 19:20:11
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm229625-1_5aseq1.html 5/A  
1 OWNERSHIP DOCUMENT tm229625-1_5aseq1.xml 5/A 3090
  Complete submission text file 0001104659-22-035171.txt   4541
Mailing Address C/O COUNSEL CORPORATION 700 - 1 TORONTO ST. TORONTO A6 M5C 2V6
Business Address
SILBER ALLAN C (Reporting) CIK: 0001009161 (see all company filings)

Type: 5/A | Act: 34 | File No.: 001-39373 | Film No.: 22750507

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations